OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 126 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,000 | -41.1% | 20,138 | -2.9% | 0.00% | – |
| Q2 2023 | $107,000 | -4.5% | 20,738 | -1.6% | 0.00% | – |
| Q1 2023 | $112,000 | +89.8% | 21,068 | 0.0% | 0.00% | – |
| Q4 2022 | $59,000 | -34.4% | 21,068 | -3.2% | 0.00% | – |
| Q3 2022 | $90,000 | +3.4% | 21,768 | 0.0% | 0.00% | – |
| Q2 2022 | $87,000 | -19.4% | 21,768 | 0.0% | 0.00% | – |
| Q1 2022 | $108,000 | -19.4% | 21,768 | +13.0% | 0.00% | – |
| Q4 2021 | $134,000 | +4.7% | 19,268 | +50.9% | 0.00% | – |
| Q3 2021 | $128,000 | -12.3% | 12,768 | +24.3% | 0.00% | – |
| Q2 2021 | $146,000 | -21.1% | 10,268 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $185,000 | -29.1% | 11,284 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $261,000 | -67.0% | 12,660 | -86.8% | 0.00% | -75.0% |
| Q2 2020 | $790,000 | – | 95,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |